Latest News about RHHBY
Recent news which mentions RHHBY
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
September 12, 2021
From Benzinga
7 Biotech Stocks to Buy That Have Millionaire-Maker Potential
September 10, 2021
From InvestorPlace
Why MacroGenics Soared Nearly 9% Higher Today
September 09, 2021
From Motley Fool
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
From Benzinga
Roche Beefs Up PCR-Test Portfolio With TIB Molbiol Acquisition
September 09, 2021
From Benzinga
2 Stocks I Bought Last Week
September 08, 2021
From Motley Fool
MacroGenics' Cancer Drug Margenza Flops On Overall Survival Analysis
September 08, 2021
From Benzinga
7 Meme Stocks You Should Keep a Close Eye on for Real Potential
September 07, 2021
From InvestorPlace
Why Adaptimmune Therapeutics Stock Is Bolting Higher Today
September 07, 2021
From Motley Fool
Adaptimmune Stock Moves Higher On Cancer Deal With Genentech
September 07, 2021
From Benzinga
Roche's Spark Therapeutics, NeuExcell Join Forces To Develop Huntington's Disease Gene Therapy
September 07, 2021
From Benzinga
Is Exelixis Stock a Buy?
September 02, 2021
From Motley Fool
COVID 19 Stocks -- Vaccines, Diagnostics, or Treatments?
August 31, 2021
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Which Biotech Stock Will Shock the Market in 2022?
August 27, 2021
From Motley Fool
Shape Therapeutics, Roche Form $3B RNA Editing Collaboration
August 24, 2021
From Benzinga
Why Shares of Global Blood Therapeutics Are Soaring Today
August 23, 2021
From Motley Fool
UK Approves Regeneron - Roche's COVID-19 Antibody Cocktail
August 20, 2021
From Benzinga
Could Biogen Acquire Axsome Therapeutics?
August 20, 2021
From Motley Fool
From Benzinga
AstraZeneca, Daiichi Sankyo's Enhertu Shows Improved PFS Over Roche's Kadcyla In Breast Cancer
August 09, 2021
From Benzinga
Genentech's Polivy Plus R-CHP Shows Prolonged Survival In Newly Diagnosed DLBCL Patients
August 09, 2021
From Benzinga
Here Are the Winners of Cowen's Big Pharma R&D Showdown
August 07, 2021
From Motley Fool
These OTC Securities Had the Most Trading Activity in July
August 06, 2021
From Benzinga
From InvestorPlace
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.